Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer

Fig. 4

Tumor- apoptotic- fraction (Casp3) of treated (Cetuximab, Pembrolizumab and Oxaliplatin) and untreated (control) tissue slices. The percentage of Casp3 positive tumor cells is depicted in Box-Jitter plots. Statistical differences were calculated using the Mann-Whitney U test and are marked (* p value ≤0.05). a- control; b- Oxaliplatin 20 μM; c- Oxaliplatin 5 μM; d- Cetuximab 200 nM; e- Cetuximab 20 nM; f- Pembrolizumab 1400 nM; g- Pembrolizumab 140 nM

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us